NLRP3 inflammasome activation and its ensuing products are present in high levels in the bronchoalveolar lavage, sputum and lung tissues of COPD patients (Colarusso et al., 2017). The gene discussed is NLRP3; the disease is chronic obstructive pulmonary disease.